Arcturus Therapeutics Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
TAK | D | Takeda Pharmaceutical Company Limited | 0.42 | |
CVAC | F | CureVac N.V. | 1.02 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PPH | D | Market Vectors Pharmaceutical ETF | 4.78 | |
FLCO | A | Franklin Liberty Investment Grade Corporate ETF | 1.02 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.64 | |
WDNA | D | WisdomTree BioRevolution Fund | 0.37 | |
FLCB | A | Franklin Liberty U.S. Core Bond ETF | 0.34 |
Compare ETFs
- Arcturus Therapeutics
Arcturus Therapeutics is an American biotech company focused on the discovery, development and commercialization of therapeutics for rare diseases with focus on RNA. Arcturus has developed a novel, potent and safe RNA therapeutics platform called LUNAR, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, gene editing, DNA, antisense, and microRNA oligotherapeutics.
The company's pipeline includes RNA therapeutics towards rare diseases such as ornithine transcarbamylase deficiency (OTCD), and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19, currently co-developed with Singaporean scientists at DukeāNUS Medical School.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles